Concepedia

Sheron Forgus

SF

Statistics

Publications

3

Citations

416

H-Index

3

Active since

2008

Affiliations

Ghent University Hospital(Current)

GlaxoSmithKline (Belgium)

Sheron Forgus is an author at Ghent University Hospital specializing in immunization, immunology, and infectious diseases.

Publications per year

2008–2012

3

Publications

3

Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial

Isabel Leroux‐Roels, Sheron Forgus, Fien De Boever et al. · Vaccine · 2012 · 160 citations

, , +14

Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study

Isabel Leroux‐Roels, François Roman, Sheron Forgus et al. · Vaccine · 2009 · 138 citations

, , +17

An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults

Karin Levie, Isabel Leroux‐Roels, Karel Hoppenbrouwers et al. · The Journal of Infectious Diseases · 2008 · 118 citations · Full text

, , +17

1–3 of 3